Connection

JAMES P ALLISON to Cytotoxicity, Immunologic

This is a "connection" page, showing publications JAMES P ALLISON has written about Cytotoxicity, Immunologic.
Connection Strength

0.323
  1. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature. 2024 Aug; 632(8023):182-191.
    View in: PubMed
    Score: 0.201
  2. Cutting edge: a crucial role for B7-CD28 in transmitting T help from APC to CTL. J Immunol. 2002 Oct 15; 169(8):4094-7.
    View in: PubMed
    Score: 0.045
  3. CD28-B7 interactions allow the induction of CD8+ cytotoxic T lymphocytes in the absence of exogenous help. J Exp Med. 1993 Jun 01; 177(6):1791-6.
    View in: PubMed
    Score: 0.023
  4. Simultaneous inhibition of two regulatory T-cell subsets enhanced Interleukin-15 efficacy in a prostate tumor model. Proc Natl Acad Sci U S A. 2012 Apr 17; 109(16):6187-92.
    View in: PubMed
    Score: 0.021
  5. T cell surveillance of oncogene-induced prostate cancer is impeded by T cell-derived TGF-?1 cytokine. Immunity. 2011 Jul 22; 35(1):123-34.
    View in: PubMed
    Score: 0.020
  6. HLA antigens in serum. Methods Enzymol. 1984; 108:614-24.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.